Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-24-008216

EVP & GENERAL COUNSEL sold 7,700 shares at $374.37 ($2,882,649)

  • EVP & GENERAL COUNSEL acquired 7,700 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

MAHON PAUL A · EVP & GENERAL COUNSEL

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-05 Exercise or conversion : show line 1 in the form 10b5-1 +7,700 $163.30 $1,257,410 44,410 D
2024-12-05 Sale : show line 2 in the form 10b5-1 −7,700 $374.37 $2,882,649 36,710 D
Open-market sales · 7,700 sh · avg $374.37 · $2,882,649

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-12-05 Exercise or conversion : show line 3 in the form 10b5-1 Share Tracking Award −7,700 $163.30 2025-03-13 7,700 45,050 D
Loading xslF345X05/primarydocument.xml…